Michele Mass

5.9k total citations
28 papers, 1.8k citations indexed

About

Michele Mass is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Michele Mass has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 7 papers in Immunology and 5 papers in Neurology. Recurrent topics in Michele Mass's work include Multiple Sclerosis Research Studies (16 papers), T-cell and B-cell Immunology (7 papers) and Immunotherapy and Immune Responses (5 papers). Michele Mass is often cited by papers focused on Multiple Sclerosis Research Studies (16 papers), T-cell and B-cell Immunology (7 papers) and Immunotherapy and Immune Responses (5 papers). Michele Mass collaborates with scholars based in United States, Slovakia and Australia. Michele Mass's co-authors include Monika Baier, Gary Cutter, Richard A. Rudick, Elizabeth Fisher, Nancy A. Simonian, Bianca Weinstock‐Guttman, D. S. Dougherty, DN Bourdette, Dale F. Kraemer and Shirley S. Kishiyama and has published in prestigious journals such as Nature Medicine, Neurology and Brain Research.

In The Last Decade

Michele Mass

28 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Mass United States 15 1.2k 410 346 260 196 28 1.8k
Enrico Millefiorini Italy 24 1.4k 1.2× 698 1.7× 354 1.0× 175 0.7× 136 0.7× 62 1.9k
Diane L. Cookfair United States 20 1.8k 1.5× 509 1.2× 458 1.3× 212 0.8× 149 0.8× 32 2.3k
Ali Manouchehrinia Sweden 25 1.6k 1.3× 503 1.2× 355 1.0× 221 0.8× 240 1.2× 73 2.1k
L. F. Kastrukoff Canada 16 1.5k 1.2× 605 1.5× 362 1.0× 272 1.0× 156 0.8× 24 1.9k
Ingrid Galán Spain 21 1.6k 1.3× 643 1.6× 475 1.4× 189 0.7× 166 0.8× 40 1.9k
Norman Putzki Switzerland 25 1.6k 1.3× 668 1.6× 293 0.8× 351 1.4× 296 1.5× 48 2.1k
S. A. Hashimoto Canada 10 1.3k 1.1× 522 1.3× 331 1.0× 204 0.8× 179 0.9× 11 1.7k
Jan Aarseth Norway 27 1.1k 1.0× 559 1.4× 170 0.5× 260 1.0× 183 0.9× 66 2.1k
Wilma J. Koopman Canada 17 1.1k 0.9× 874 2.1× 379 1.1× 113 0.4× 191 1.0× 37 1.9k
Edgardo Cristiano Argentina 23 1.1k 0.9× 486 1.2× 278 0.8× 211 0.8× 115 0.6× 116 1.7k

Countries citing papers authored by Michele Mass

Since Specialization
Citations

This map shows the geographic impact of Michele Mass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Mass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Mass more than expected).

Fields of papers citing papers by Michele Mass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Mass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Mass. The network helps show where Michele Mass may publish in the future.

Co-authorship network of co-authors of Michele Mass

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Mass. A scholar is included among the top collaborators of Michele Mass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Mass. Michele Mass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Falardeau, Julie, Gail Marracci, Michele Mass, et al.. (2019). Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(2). 2454270161–2454270161. 10 indexed citations
2.
Yadav, Vijayshree, Michele Mass, Gail Marracci, et al.. (2017). Oral lipoic acid as a treatment for acute optic neuritis: A blinded, placebo-controlled randomized trial (P6.388). Neurology. 88(16_supplement). 1 indexed citations
3.
Applebee, Angela, François Béthoux, Myla Goldman, et al.. (2014). Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis. International Journal of MS Care. 17(3). 138–145. 14 indexed citations
4.
Vandenbark, Arthur A., Nicole Culbertson, Richard M. Bartholomew, et al.. (2007). Therapeutic vaccination with a trivalent T‐cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis. Immunology. 123(1). 66–78. 59 indexed citations
5.
Bourdette, Dennis, E.V.J. Edmonds, Cassandra Smith, et al.. (2005). A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. Multiple Sclerosis Journal. 11(5). 552–561. 61 indexed citations
6.
Baier, Monika, Gary Cutter, R. A. Rudick, et al.. (2005). Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology. 64(6). 992–995. 124 indexed citations
7.
Rudick, Richard A., Gary Cutter, Monika Baier, et al.. (2005). Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients. Multiple Sclerosis Journal. 11(6). 626–634. 42 indexed citations
8.
Vandenbark, Arthur A., Tom Finn, David W. Barnes, et al.. (2001). Diminished frequency of interleukin‐10‐secreting, T‐cell receptor peptide‐reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV gene. Journal of Neuroscience Research. 66(2). 171–176. 10 indexed citations
9.
Rudick, Richard A., Gary Cutter, Monika Baier, et al.. (2001). Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology. 56(10). 1324–1330. 96 indexed citations
10.
Fisher, Elizabeth, Richard A. Rudick, Gary Cutter, et al.. (2000). Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. Multiple Sclerosis Journal. 6(6). 373–377. 139 indexed citations
11.
Jones, Richard E., Michele Mass, & Dennis Bourdette. (1999). Myelin basic protein-specific T lymphocytes induce chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice. Journal of Neuroimmunology. 93(1-2). 92–101. 9 indexed citations
12.
Remsen, Laura G., Christopher McCormick, Gerard P. Sexton, et al.. (1997). Long-term Toxicity and Neuropathology Associated with the Sequencing of Cranial Irradiation and Enhanced Chemotherapy Delivery. Neurosurgery. 40(5). 1034–1042. 13 indexed citations
13.
Nance, Patricia W., W. A. Sheremata, Sharon Lynch, et al.. (1997). Relationship of the Antispasticity Effect of Tizanidine to Plasma Concentration in Patients With Multiple Sclerosis. Archives of Neurology. 54(6). 731–736. 61 indexed citations
14.
Burton, J.H., Michele Mass, James J. Menegazzi, & D.M. Yealy. (1997). Aminophylline as an Adjunct to Standard Advanced Cardiac Life Support in Prolonged Cardiac Arrest. Annals of Emergency Medicine. 30(2). 154–158. 10 indexed citations
15.
Vandenbark, Arthur A., Yuan K. Chou, Ruth H. Whitham, et al.. (1996). Treatment of multiple sclerosis with T–cell receptor peptides: Results of a double–blind pilot trial. Nature Medicine. 2(10). 1109–1115. 141 indexed citations
16.
Wingett, Denise, et al.. (1996). Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V?-specific antibodies when proteolipid protein is the autoantigen. Journal of Neuroscience Research. 45(2). 104–116. 9 indexed citations
17.
Jones, Richard E., Yuan K. Chou, Amy Young, et al.. (1995). T cells with encephalitogenic potential from multiple sclerosis patients and Lewis rats fail to induce disease in SCID mice following intracisternal injection. Journal of Neuroimmunology. 56(2). 119–126. 7 indexed citations
18.
Jones, Richard E., Ruth H. Whitham, Timothy J. Sullivan, Michele Mass, & Dennis Bourdette. (1995). Encephalitogenic T lymphocytes develop from SJL/J hematopoietic cells transplanted into severe combined immimodeficient ( SCID) mice. Journal of Neuroimmunology. 57(1-2). 155–164. 5 indexed citations
19.
Roman-Goldstein, Simon, Peggy A. Barnett, Christopher McCormick, et al.. (1994). Effects of Gd-DTPA after Osmotic BBB Disruption in a Rodent Model. Journal of Computer Assisted Tomography. 18(5). 731–736. 22 indexed citations
20.
Seil, Fredrick J., et al.. (1989). Myelination of axons within cytosine arabinoside treated mouse cerebellar explants by cultured rat oligodendrocytes. Brain Research. 503(1). 111–117. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrico Millefiorini Breakdown of academic impact, for papers by Diane L. Cookfair Breakdown of academic impact, for papers by Ali Manouchehrinia Breakdown of academic impact, for papers by L. F. Kastrukoff Breakdown of academic impact, for papers by Ingrid Galán Breakdown of academic impact, for papers by Norman Putzki Breakdown of academic impact, for papers by S. A. Hashimoto Breakdown of academic impact, for papers by Jan Aarseth Breakdown of academic impact, for papers by Wilma J. Koopman Breakdown of academic impact, for papers by Edgardo Cristiano
Rankless by CCL
2026